Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Online physical activity coaching for people with Parkinson's in Qatar

Official title: A Pilot RCT of a Remote Physical Activity Coaching Intervention to Promote Engagement in Physical Activity for People With Parkinson's Disease in Qatar

Run by Qatar University · NCT06962930 · Data updated 2026-11-12

This project will test an 8-week personalized online physical activity coaching program, with one in-person session and seven online sessions, for adults with Parkinson's in Qatar.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorQatar University
Academic / other
Locations3 sites (Doha and 2 other locations)
StatusRecruiting
StartedSeptember 10, 2025
Main results expectedMay 10, 2026
Study endsSeptember 10, 2026
Registry record updatedSeptember 29, 2025
Trial IDNCT06962930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults in Qatar with a neurologist-confirmed Parkinson's diagnosis who are ambulatory (with or without assistive devices), can follow study commands, and who pass the PAR-Q or provide medical clearance.

Probably not a fit

People with other neurological disorders, musculoskeletal injuries or acute illnesses that prevent safe exercise, or those who require physical assistance to walk are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Engage-Qatar PD will adapt an existing coaching program into an online, culturally tailored eight-week self-management course for people with Parkinson's in Qatar. Development will use participatory design methods with patients serving as co-designers to ensure cultural relevance and usability. Participants will receive one face-to-face coaching session followed by seven online sessions personalized to their abilities and goals. The primary focus of this stage is adapting content and delivery for online use within the Qatari context rather than measuring long-term clinical outcomes.

Why it matters

Potential benefit: If successful, the program could help people with Parkinson's increase regular physical activity, improve function and quality of life, and gain culturally appropriate self-management skills.

How similar studies have gone: Personalized coaching approaches have shown promise in Huntington's disease and some Parkinson's programs, but online, culturally adapted delivery in Qatar remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age above 18 years.
2. Successful completion of Physical Activity Readiness Questionnaire (PAR-Q), or medical clearance from a neurologist.
3. Ambulatory for indoor and outdoor mobility with or without an assistive device but without physical assistance.
4. A neurologist-confirmed diagnosis of PD.
5. Ability to follow study-related commands.

Exclusion Criteria:

1. Musculoskeletal injury or a medical condition that would prevent safe participation in an exercise program including failure to pass the PAR-Q test.
2. The presence of any other neurological conditions.
3. Acute illness or injury that prevents participation in the intervention.

Where it's running

  • Qatar Rehabilitation Institution
    Doha, Qatar
    Recruiting
  • Rumaila Hospital
    Doha, Qatar
    Recruiting
  • Qatar University
    Doha, Qatar
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.